Biosimilars as antivirals: opportunities and challenges

Expert Rev Anti Infect Ther. 2024 Jan 30:1-3. doi: 10.1080/14787210.2024.2313064. Online ahead of print.NO ABSTRACTPMID:38288681 | DOI:10.1080/14787210.2024.2313064
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Authors: Source Type: research